| Hyperlipidemia with hypoglycemia reduces myocardial oxygen utilization efficiency but not contractile function during coronary hypoperfusion. | |
| | |
MedLine Citation:
|
PMID: 10900179 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This study was designed to determine changes in myocardial contractile function and fuel selection during moderate coronary hypoperfusion in the presence of elevated plasma free fatty acid (FFA) at normal and reduced blood glucose concentrations. Coronary perfusion pressure (CPP) was sequentially lowered from 100 to 60, 50, and 40 mmHg in the left anterior descending coronary artery (LAD) of anesthetized, open-chest dogs. Regional glucose uptake (GU), fatty acid uptake (FAU), percentage segment shortening (%SS), and oxygen consumption (MV O(2)) were determined with normal arterial plasma FFA concentrations (Group 1) or with elevated FFA concentrations (Groups 2 and 3). In Group 3, glucose in the coronary perfusate blood was reduced from 3.53+/-0.36 to 0.15+/-0.03 m M by hemodialysis. In Group 1, FAU fell by 85% as CPP was lowered to 60 mmHg and remained depressed as CPP was reduced further; GU did not fall significantly. Hyperlipidemia in Group 2 did not alter GU at any CPP, but maintained FAU at baseline levels until CPP was lowered to 40 mmHg. At 40 mmHg CPP, myocardial function and metabolic variables were similar in Groups 1 and 2. In Group 3 at 40 mmHg, FAU increased four-fold and MV O(2)doubled v Groups 1 and 2, and GU fell to zero. Despite these metabolic changes, %SS in Group 3 was unchanged relative to Group 2. Addition of glucose to the dialysate prevented the effects of dialysis on FAU, GU, and MV O(2). Thus, preferential glucose oxidation sustains myocardial oxygen utilization efficiency [(heart rate x %SS x maximum left ventricular pressure)/MV O(2)] during hypoperfusion. Blocking preferential glucose oxidation by combined hyperlipidemia and hypoglycemia lowers oxygen utilization efficiency, but does not compromise myocardial contractile function. |
| | |
Authors:
|
B J Hart; X Bian; R T Mallet; H F Downey |
Related Documents
:
|
12821539 - Novel index for invasively assessing the coronary microcirculation. 3521579 - Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death. 6183019 - Renin-angiotensin system inhibition in acute myocardial infarction in dogs. effects on ... 9085349 - Role of nitric oxide (no) in the regulation of coronary circulation. 8189709 - In-vivo study of the mechanical properties of epicardial coronary arteries. 8125889 - Exercise training alters myogenic responses in porcine coronary resistance arteries. 7009689 - The anesthetic management of the severely burned patient. 2000019 - Gas composition and pressure in the middle ear: a model for the physiological steady st... 6848459 - Accuracy of auscultatory blood pressure measurements in hypertensive and obese subjects. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Journal of molecular and cellular cardiology Volume: 32 ISSN: 0022-2828 ISO Abbreviation: J. Mol. Cell. Cardiol. Publication Date: 2000 Aug |
Date Detail:
|
Created Date: 2000-10-06 Completed Date: 2000-10-06 Revised Date: 2011-03-09 |
Medline Journal Info:
|
Nlm Unique ID: 0262322 Medline TA: J Mol Cell Cardiol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 1539-52 Citation Subset: IM |
Copyright Information:
|
Copyright 2000 Academic Press. |
Affiliation:
|
Department of Integrative Physiology, University of North Texas Health Science Center at Fort Worth, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107-2699, USA. bhart@hsc.unt.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Glucose / metabolism Dogs Fatty Acids / blood Female Glucose / metabolism Glycogen / blood Hemodynamics Hyperlipidemias / metabolism* Hypoglycemia / metabolism* Ischemia Lactic Acid / blood Male Myocardial Contraction / physiology* Myocardium / metabolism* Oxygen / blood, metabolism* Oxygen Consumption Perfusion Pressure |
| Grant Support | |
ID/Acronym/Agency:
|
HL35027/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Fatty Acids; 50-21-5/Lactic Acid; 50-99-7/Glucose; 7782-44-7/Oxygen; 9005-79-2/Glycogen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rate-dependency of action potential duration and refractoriness in isolated myocytes from the rabbit...
Next Document: Isoenzyme-specific protein kinase C and c-Jun N-terminal kinase activation by electrically stimulate...